UQ licenses hGH to PROLOR
12 August, 2009 by Staff WritersIMBcom and PROLOR Biotech enter into technology licence for human growth hormone.
Prognosis good for Primary Health Care
12 August, 2009 by Tim DeanProfits up more than tenfold following acquisition of Symbion in 2008.
BioProspect acquisition of Re-Gen complete
10 August, 2009 by Staff WritersPlans to expand into rapidly growing Chinese market for natural health products.
Australian biotech market watch 07/08/09
07 August, 2009 by Tim DeanResMed, Ramsay, Biota, Sonic, Healthscope
Mesoblast targets heart failure in trial
05 August, 2009 by Tim DeanAdult stem cells might eliminate the need for heart transplants in heart failure patients.
FDA-approved manufacturing plant opens in Sydney
05 August, 2009 by Tim DeanFacility for manufacture of highly potent sterile injectables opened by Parnell.
Starpharma announces positive trial results
04 August, 2009 by Tim DeanVivaGel demonstrates anti-HIV and herpes simplex virus properties.
Australian biotech market watch 31/07/09
31 July, 2009 by Tim DeanHeartWare, Universal Biosensors, Fisher & Paykel, CSL
Trial of electrical stimulation treatment for depression
28 July, 2009 by Staff WritersParticipants sought for trial using electrical brain stimulation to treat depression.
New method produces better biological factories
27 July, 2009 by Staff WritersParallel gene manipulation speeds up creation of lycopene-producing bacteria.
Australian biotech market watch 24/07/09
24 July, 2009 by Tim DeanAnsell, CathRX, CSL, Primary Health Care, Sirtex, Living Cell Technologies, Biota, Cochlear
New drug may reduce heart attack damage
23 July, 2009 by Staff WritersOne-off drug delivery could dramatically improve treatment of Australia’s number one killer.
Australian biotech market watch 22/07/09
22 July, 2009 by Tim DeanCochlear, Fisher & Paykel, Ramsay, ResMed, Sigma, Sonic Health Care, Primary Health Care
Life and death of a white blood cell
21 July, 2009 by Staff WritersCell division find prompts overhaul of immune response modelling.
ChemGenex appoints new CCO
20 July, 2009 by Tim DeanNew chief commercial officer and senior vice president appointed ahead of omacetaxine launch in 2010.
